Insider · CIK 0002053381
Kevin Finney
Files at VXRT (Vaxart, Inc.). First filing Aug 19, 2025, latest Aug 19, 2025.
Kevin Finney files SEC Form 4 as director at VXRT (Vaxart, Inc.). Since Aug 19, 2025, Kevin Finney has reported 1 open-market buy worth $62k and 0 open-market sells worth $0, the latest filed on Aug 19, 2025.
A track record needs three past buys with six months of prices behind them; Kevin Finney has 0, so none is measured yet.
The newest scored trade: bought $62k of VXRT on Jul 17, 2025, filed Aug 19, 2025, scored 40 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
VXRT: Vaxart, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | Vaxart, Inc. | $62k 166,668 shares | +437% | - |
Transactions
Every row this insider has filed, 10 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 17, 2025 | VXRT Vaxart, Inc. | POpen-market purchase Common Stock | +794 | $0.38 | $302 | 38,897 | Aug 19, 2025 |
| Jul 25, 2025 | VXRT Vaxart, Inc. | POpen-market purchase Common Stock | +20,000 | $0.39 | $7,800 | 58,897 | Aug 19, 2025 |
| Jul 28, 2025 | VXRT Vaxart, Inc. | POpen-market purchase Common Stock | +20,000 | $0.40 | $8,000 | 78,897 | Aug 19, 2025 |
| Jul 30, 2025 | VXRT Vaxart, Inc. | POpen-market purchase Common Stock | +25,874 | $0.38 | $9,832 | 104,771 | Aug 19, 2025 |
| Aug 15, 2025 | VXRT Vaxart, Inc. | POpen-market purchase Common Stock | +50,000 | $0.35 | $18k | 154,771 | Aug 19, 2025 |
| Aug 15, 2025 | VXRT Vaxart, Inc. | POpen-market purchase Common Stock | +50,000 | $0.37 | $19k | 204,771 | Aug 19, 2025 |
| Jun 13, 2025 | VXRT Vaxart, Inc. | AGrant or award Common Stock | +6,103 | $0.00 | $0 | 38,103 | Jun 16, 2025 |
| Jun 13, 2025 | VXRT Vaxart, Inc. | AGrant or award Stock Option (right to buy)derivative | +36,392 | $0.00 | $0 | 36,392 | Jun 16, 2025 |
| Jan 28, 2025 | VXRT Vaxart, Inc. | AGrant or award Common Stock | +32,000 | $0.00 | $0 | 32,000 | Jan 29, 2025 |
| Jan 28, 2025 | VXRT Vaxart, Inc. | AGrant or award Stock Option (right to buy)derivative | +190,800 | $0.00 | $0 | 190,800 | Jan 29, 2025 |
Questions about Kevin Finney
Answered from the filings on this page, as of the latest one.
Is Kevin Finney buying or selling?
Not in the last 12 months. Kevin Finney's latest open-market trade on SEC Form 4 was bought $62k of VXRT on Jul 17, 2025.
How did Kevin Finney's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kevin Finney has 0.
Where does Kevin Finney file Form 4?
Kevin Finney has filed Form 4 at VXRT (Vaxart, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.